IP Library Granted Patent US 12,139,555
Granted Patent B2
US 12,139,555 · App. 17/779,307 · Granted Nov 12, 2024

Peptides and compositions for inhibiting hair growth

Inventors: Kathryn P. Rodan (Oakland, CA); Kathy A. Fields (San Francisco, CA); John Simon Craw (San Francisco, CA)
Assignee: RODAN & FIELDS, LLC
C07K7/06A61K8/64A61Q7/02C07K5/0819C07K5/101C07K5/1019C07K5/1021
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,139,555
App. No.
17/779,307
Granted
Nov 12, 2024
Kind
B2
Abstract

Synthetic peptides which have been shown to be FGF 18 agonists are described. Topical compositions for decreasing, eliminating, or suppressing hair growth are disclosed herein. Methods for reducing hair growth, improving the appearance of skin, kits, and related cosmetic formulations are also provided herein.

Claims (24)

1. A topical composition comprising an effective amount of a fibroblast growth factor 18 (FGF18) agonist peptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO: 2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, DRV, and combinations thereof, and a cosmetically acceptable excipient, wherein the topical composition is formulated as a lotion, cream, serum, spray, mousse, aerosol, emulsion, cake, ointment, gel, paste, patch, pencil, towelette, mask, stick, foam, elixir, oil-in-water emulsion (O/W), water-in-oil (W/O) emulsion, microemulsion, or concentrate.

2. The topical composition of claim 1 , wherein the effective amount of one of more fibroblast growth factor 18 (FGF18) agonist peptides is about 0.00001% to about 1% w/w in the topical composition.

3. The topical composition of claim 1 , wherein the effective amount of one of more fibroblast growth factor 18 (FGF18) agonist peptides is about 1 ng/ml to about 100 ng/ml in the topical composition.

4. The topical composition of claim 1 , wherein the effective amount of one of more fibroblast growth factor 18 (FGF18) agonist peptides is about 1 uM to about 10 uM in the topical composition.

5. The topical composition of claim 1 , wherein the effective amount of one of more fibroblast growth factor 18 (FGF18) agonist peptides is about 0.01 ug to about 1000 ug in the topical composition.

6. The topical composition of claim 1 , wherein the cosmetically acceptable excipient is selected from the group consisting of a diluent, a solvent, a surfactant, a thickening agent, a foaming agent, a gelling agent, an emulsifier, a water soluble vehicle, a hydrophobic vehicle, a viscosity modifier, an antioxidant, a buffer, a skin protectant, a chelating agent, a fragrance, a preservative, a surfactant, a lubricant, a penetration enhancer, a humectant, a moisturizer, a solubilizer, a plasticizer, a propellant, an alcohol, an emollient, and combinations thereof.

7. The topical composition of claim 1 , wherein the cosmetically acceptable excipient includes glycerin, water, and sodium levulinate.

8. The topical composition of claim 1 , wherein the topical composition further comprises an agent selected from the group consisting of a lathering surfactant, a moisturizer, an anti-dandruff agent, a vitamin, a hydroxy acid, a chemical or physical sunscreen, an antioxidant, a retinoid, a progesterone, and combinations thereof.

9. A topical composition comprising:

(i) an effective amount of a fibroblast growth factor 18 (FGF18) agonist peptide consisting of:

(a) an amino acid sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO: 2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, DRV, and combinations thereof; and

(b) a protection group linked at the N-terminus of the amino acid sequence, wherein the protection group is selected from the group consisting of: an acetyl group, a fluorenyl methoxy carbonyl group, a formyl group, a palmitoyl group, a myristyl group, a stearyl group, a linoleate group, a polyethylene glycol (PEG), and other cosmetically acceptable protecting groups; and

(ii) a cosmetically acceptable excipient, wherein the topical composition is formulated as a lotion, cream, serum, spray, mousse, aerosol, emulsion, cake, ointment, gel, paste, patch, pencil, towelette, mask, stick, foam, elixir, oil-in-water emulsion (O/W), water-in-oil (W/O) emulsion, microemulsion, or concentrate.

10. A method for decreasing, or eliminating hair growth in a subject comprising topically administering to a target location on the subject a topical composition comprising an effective amount of one or more fibroblast growth factor 18 (FGF18) agonist peptides consisting of amino acid sequences selected from the group consisting of SEQ ID NO:1, SEQ ID NO: 2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, DRV, and combinations thereof, and a cosmetically acceptable excipient, wherein the topical composition is formulated as a lotion, cream, serum, spray, mousse, aerosol, emulsion, cake, ointment, gel, paste, patch, pencil, towelette, mask, stick, foam, elixir, oil-in-water emulsion (O/W), water-in-oil (W/O) emulsion, microemulsion, or concentrate.

11. The method of claim 10 , wherein the effective amount of one of more fibroblast growth factor 18 (FGF18) agonist peptides is about 0.00001% to about 1% w/w in the topical composition.

12. The method of claim 10 , wherein the effective amount of one of more fibroblast growth factor 18 (FGF18) agonist peptides is about 1 ng/ml to about 100 ng/ml in the topical composition.

13. The method of claim 10 , wherein the effective amount of one of more fibroblast growth factor 18 (FGF18) agonist peptides is about 1 uM to about 10 uM in the topical composition.

14. The method of claim 10 , wherein the effective amount of one of more fibroblast growth factor 18 (FGF18) agonist peptides is about 0.01 ug to about 1000 ug in the topical composition.

15. The method of claim 10 , further comprising administering a second skin care composition to the target location after the topical composition is applied.

16. The method of claim 10 , wherein the target location is selected from the group consisting of scalp, face, body, eyebrow, and combinations thereof.

17. The method of claim 10 , wherein the target location does not normally grow hair.

18. The method of claim 10 , wherein the topical composition further comprises an agent selected from the group consisting of a lathering surfactant, a moisturizer, an anti-dandruff agent, a vitamin, a hydroxy acid, a chemical or physical sunscreen, an antioxidant, a retinoid, and a progesterone.

19. The method of claim 10 , wherein the topical composition is administered daily, weekly, twice weekly, every two weeks, every three weeks, or monthly.

20. The method of claim 10 , wherein the topical composition is administered using an applicator device.

Assignments (10)
ASSIGNMENT OF SECURITY INTERESTS IN PATENT COLLATERAL Recorded Feb 2, 2026
From: CITIBANK, N.A., IN ITS CAPACITY AS THE WITHDRAWING AGENT
To: ANKURA TRUST COMPANY, LLC, IN ITS CAPACITY AS SUCCESSOR AGENT
Reel/Frame 074643/0097 →
MERGER Recorded Oct 9, 2024
From: RODAN & FIELDS, LLC
To: RODAN & FIELDS BEAUTY, LLC
Reel/Frame 068844/0351 →
PATENT SECURITY AGREEMENT Recorded Sep 27, 2024
From: RODAN & FIELDS BEAUTY, LLC
To: ANKURA TRUST COMPANY, LLC, AS COLLATERAL AGENT
Reel/Frame 069066/0818 →
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL RECORDED ON APRIL 28, 2023, AT REEL/FRAME 063480/0786 Recorded Sep 27, 2024
From: ANKURA TRUST COMPANY, LLC, AS COLLATERAL AGENT
To: RODAN & FIELDS, LLC
Reel/Frame 069066/0803 →
PATENT SECURITY AGREEMENT Recorded Sep 27, 2024
From: RODAN & FIELDS BEAUTY, LLC
To: ANKURA TRUST COMPANY, LLC, AS COLLATERAL AGENT
Reel/Frame 069066/0810 →
SECURITY INTEREST Recorded May 2, 2023
From: RODAN & FIELDS, LLC
To: CITIBANK, N.A.
Reel/Frame 063501/0785 →
SECURITY INTEREST Recorded May 2, 2023
From: RODAN & FIELDS, LLC
To: ANKURA TRUST COMPANY, LLC
Reel/Frame 063501/0804 →
SECURITY INTEREST Recorded Apr 28, 2023
From: RODAN & FIELDS, LLC
To: ANKURA TRUST COMPANY, LLC
Reel/Frame 063480/0786 →
SECURITY INTEREST Recorded Apr 28, 2023
From: RODAN & FIELDS, LLC
To: ANKURA TRUST COMPANY, LLC
Reel/Frame 063480/0179 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2022
From: CRAW, JOHN SIMON; FIELDS, KATHY A.; RODAN, KATHRYN P.
To: RODAN & FIELDS, LLC
Reel/Frame 061107/0110 →
Continuity (2)
Provisional Application 62942862 · Dec 3, 2019
Related Publication 20230002447A1 · Jan 5, 2023